Abstract:In recent years, multidrug-resistant pathogenic microorganisms (MDROs) have emerged as a severe threat to human health, exhibiting robust resistance to traditional antibiotics. This has created a formidable challenge in modern medicine as we grapple with limited options to combat these resilient bacteria. Despite extensive efforts by scientists to develop new antibiotics targeting these pathogens, the quest for novel antibacterial molecules has become increasingly arduous. Fortunately, nature offers a potential solution in the form of cationic antimicrobial peptides (AMPs) and their synthetic counterparts. AMPs, naturally occurring peptides, have displayed promising efficacy in fighting bacterial infections by disrupting bacterial cell membranes, hindering their survival and reproduction. These peptides, along with their synthetic mimics, present an exciting alternative in combating antibiotic resistance. They hold the potential to emerge as a formidable tool against MDROs, offering hope for improved strategies to protect communities. Extensive research has explored the diversity, history, and structure-properties relationship of AMPs, investigating their amphiphilic nature for membrane disruption and mechanisms of action. However, despite their therapeutic promise, AMPs face several documented limitations. Among these challenges, poor pharmacokinetic properties stand out, impeding the attainment of therapeutic levels in the body. Additionally, some AMPs exhibit toxicity and susceptibility to protease cleavage, leading to a short half-life and reduced efficacy in animal models. These limitations pose obstacles in developing effective treatments based on AMPs. Furthermore, the high manufacturing costs associated with AMPs could significantly hinder their widespread use. In this review, we aim to present experimental and theoretical insights into different AMPs, focusing specifically on antibacterial peptides (ABPs). Our goal is to offer a concise overview of peptide-based drug candidates, drawing from a wide array of literature and peer-reviewed studies. We also explore recent advancements in AMP development and discuss the challenges researchers face in moving these molecules towards clinical trials. Our main objective is to offer a comprehensive overview of current AMP and ABP research to guide the development of more precise and effective therapies for bacterial infections.

Design methods for antimicrobial peptides with improved performance

Using chemical synthesis to optimise antimicrobial peptides in the fight against antimicrobial resistance

Chemical modifications to increase the therapeutic potential of antimicrobial peptides

Antimicrobial Peptides: From Design to Clinical Application

Antimicrobial Peptides: Design, Chemical Synthesis, Activity Evaluation, and Application

Design, Optimization, and Nanotechnology of Antimicrobial Peptides: from Exploration to Applications

Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo

Advancements in peptide-based antimicrobials: A possible option for emerging drug-resistant infections

Chemically modified and conjugated antimicrobial peptides against superbugs.

Antimicrobial Peptides and Proteins: From Nature’s Reservoir to the Laboratory and Beyond

Antimicrobial peptide-based strategies to overcome antimicrobial resistance

Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance

[Progress on the design and optimization of antimicrobial peptides]

Beyond Conventional Drug Design: Exploring the Broad‐Spectrum Efficacy of Antimicrobial Peptides

Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance

Antimicrobial Peptides and Their Biomedical Applications: A Review

Towards the Development of Synthetic Antibiotics: Designs Inspired by Natural Antimicrobial Peptides

Engineering Approaches for the Development of Antimicrobial Peptide-Based Antibiotics

Integrated computational approaches for advancing antimicrobial peptide development

Antimicrobial Peptides: Recent Insights on Biotechnological Interventions and Future Perspectives